Bloom emerges with microbiome tech from UCLA

Bloom Science Inc. (San Diego, Calif.) launched May 24 to develop microbiome-based therapeutics to treat epilepsy utilizing technology from the University of California Los Angeles. The UCLA group also published a paper in Cell on May 24 showing that a ketogenic diet is beneficial in controlling epileptic seizures due to its influence on the gut microbiome, which in turn mediates hippocampal GABA and glutamate ratios.

The ketogenic diet is a high-fat, low-carbohydrate diet that has previously been shown to help treat epilepsy...